Effects of surface coating on the controlled release of vitamin B, from mesoporous silica tablets

被引:64
作者
Wu, Zhijian [1 ]
Jiang, Yan
Kim, Taehoon
Lee, Kangtaek
机构
[1] Huaqiao Univ, Coll Mat Sci & Engn, Quanzhou 362021, Peoples R China
[2] Chinese Acad Sci, Qinghai Inst Salt Lakes, Xining 810008, Peoples R China
[3] Yonsei Univ, Dept Chem Engn, Seoul 120749, South Korea
关键词
mesoporous silica; vitamin B-1; organosilane; coating; controlled release;
D O I
10.1016/j.jconrel.2007.03.001
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The controlled release of vitamin B-1 (VB1, thiamine hydrochloride) from mesoporous silica tablets coated with a series of sol-gel coatings was investigated. Tetraethoxysilane (TEOS), n-propyltrietboxysilane (PTES), n-octyltriethoxysilane (OTES), bis(trimethoxysilyl)hexane (TSH), his (triethoxysilyl)octane (TSO), bis (trimethoxysilylpropyl)amine (TSPA), and bis[(3-trimethoxysilyl)propyl]ethylenediamine (TSPED) were used as precursors for the coatings. The effects of organosilane type and concentration, the number of coatings, drying temperature, and release media on VB1 release from the coated mesoporous silica tablets were comprehensively examined. The TSH, TSO, TSPA, and TSPED coatings were found to be more effective in suppression of release than the other coatings. VB1 release decreases with the increase in the number of coatings and drying temperature. It was found that there is an optimal coating solution concentration for the controlled release. In general, more VB1 is released in 0.01 M HCl solution than in 0.05 M phosphate buffer solution at pH 7.4 because of the electrostatic repulsions between the protonated VB1 cations and the positively charged mesoporous silica carrier/coatings. The experimental results show that drug release can be easily controlled by changing the organosilane type and the number of coating. The method used in this study is an effective and flexible way for controlled release due to the high drug loading and the easy control of release rate. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 54 条
[21]   Alkyl-substituted silica gel as a carrier in the controlled release of dexmedetomidine [J].
Kortesuo, P ;
Ahola, M ;
Kangas, M ;
Leino, T ;
Laakso, S ;
Vuorilehto, L ;
Yli-Urpo, A ;
Kiesvaara, J ;
Marvola, M .
JOURNAL OF CONTROLLED RELEASE, 2001, 76 (03) :227-238
[22]   In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol-gel synthesis parameters [J].
Kortesuo, P ;
Ahola, M ;
Kangas, M ;
Yli-Urpo, A ;
Kiesvaara, J ;
Marvola, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 221 (1-2) :107-114
[23]   Controlled release of avermectin from porous hollow silica nanoparticles: Influence of shell thickness on loading efficiency, UV-shielding property and release [J].
Li, ZZ ;
Xu, SA ;
Wen, LX ;
Liu, F ;
Liu, AQ ;
Wang, Q ;
Sun, HY ;
Yu, W ;
Chen, JF .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :81-88
[24]   Fabrication of porous hollow silica nanoparticles and their applications in drug release control [J].
Li, ZZ ;
Wen, LX ;
Shao, L ;
Chen, JF .
JOURNAL OF CONTROLLED RELEASE, 2004, 98 (02) :245-254
[25]   Poly(dimethylsiloxane) coatings for controlled drug release - polymer modifications [J].
Nahrup, JS ;
Gao, ZM ;
Mark, JE ;
Sakr, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 270 (1-2) :199-208
[26]   In vitro release kinetics of biologically active transforming growth factor-beta 1 from a novel porous glass carrier [J].
Nicoll, SB ;
Radin, S ;
Santos, EM ;
Tuan, RS ;
Ducheyne, P .
BIOMATERIALS, 1997, 18 (12) :853-859
[27]   Effective controlled release of captopril by silylation of mesoporous MCM-41 [J].
Qu, FY ;
Zhu, GS ;
Huang, SY ;
Li, SG ;
Qiu, SL .
CHEMPHYSCHEM, 2006, 7 (02) :400-406
[28]  
Radin S, 2001, J BIOMED MATER RES, V57, P313, DOI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO
[29]  
2-E
[30]   Mesoporous MCM-41 as drug host system [J].
Rámila, A ;
Muñoz, B ;
Pérez-Pariente, J ;
Vallet-Regí, M .
JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY, 2003, 26 (1-3) :1199-1202